Incendia Therapeutics
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A First-in-human Study of PRTH-101 Monotherapy +/- Pembrolizumab in Subjects With Advanced Malignancies (NCT05753722) | Incendia Therapeutics | 2023-03-03 |
Track Incendia Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.